{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:52:53Z","timestamp":1791215573802,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":212,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642179686","type":"print"},{"value":"9783642179693","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-17969-3_1","type":"book-chapter","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T11:32:33Z","timestamp":1308655953000},"page":"1-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Phosphodiesterase Inhibitors: History of Pharmacology"],"prefix":"10.1007","author":[{"given":"Christian","family":"Schudt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Hatzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Beume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Tenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,6]]},"reference":[{"key":"1_CR1_1","first-page":"510","volume":"80","author":"E Allard","year":"1904","unstructured":"Allard E (1904) \u00dcber Theocinvergiftung. Arch Klin Med 80:510\u2013519","journal-title":"Arch Klin Med"},{"key":"1_CR2_1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.RES.45.5.666","volume":"45","author":"AA Alousi","year":"1979","unstructured":"Alousi AA, Farah AE, Lesher GY, Opalka CJ (1979) Cardiotonic activity of amrinone-Win 40680 [5-amino-3, 4\u2019-bipyridine-6(1H)-one]. Circ Res 45:666\u2013677","journal-title":"Circ Res"},{"key":"1_CR3_1","first-page":"762","volume":"85","author":"American Thoracic Society","year":"1962","unstructured":"American Thoracic Society (1962) Definitions and classifications of chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 85:762\u2013768","journal-title":"Am Rev Respir Dis"},{"key":"1_CR4_1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1398-9995.1980.tb01718.x","volume":"35","author":"P Andersson","year":"1980","unstructured":"Andersson P (1980) Antigen-induced brochial anaphylaxis in actively sensitized guinea pigs. Allergy 35:65\u201371","journal-title":"Allergy"},{"key":"1_CR5_1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/sj.bjp.0701723","volume":"123","author":"BT Au","year":"1998","unstructured":"Au BT, Teixeira MM, Collins PD, Williams TJ (1998) Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol. Br J Pharmacol 123:1260\u20131266","journal-title":"Br J Pharmacol"},{"key":"1_CR6_1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/thx.53.2.137","volume":"53","author":"PJ Barnes","year":"1998","unstructured":"Barnes PJ (1998) New therapies for chronic obstructive pulmonary disease. Thorax 53:137\u2013147","journal-title":"Thorax"},{"key":"1_CR7_1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1164\/rccm.200210-1142PP","volume":"167","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ (2003a) Theophylline, new perspectives of an old drug. Am J Respir Crit Care Med 167:813\u2013818","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR8_1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev.med.54.101601.152209","volume":"54","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ (2003b) New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54:113\u2013129","journal-title":"Annu Rev Med"},{"key":"1_CR9_1","first-page":"1665","volume":"33","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ, Celli B (2008) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1665\u20131685","journal-title":"Eur Respir J"},{"key":"1_CR10_1","first-page":"425","volume-title":"Asthma and COPD. Basic mechanisms and clinical management","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ, Rennard SI (2008) Pathophysiology of COPD. In: Barnes PJ, Drazen J, Rennard SI, Thomson N (eds) Asthma and COPD. Basic mechanisms and clinical management. Academic, Amsterdam, pp 425\u2013442"},{"key":"1_CR11_1","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.1074\/jbc.M407521200","volume":"280","author":"AP Barnes","year":"2005","unstructured":"Barnes AP, Livera G, Huang P, Sun C, O\u2019Neal WK, Conti M, Stutts MJ, Milgram SL (2005) Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium. J Biol Chem 280:7997\u20138003","journal-title":"J Biol Chem"},{"key":"1_CR12_1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0022-3565(25)09664-8","volume":"273","author":"MS Barnette","year":"1995","unstructured":"Barnette MS, Grous M, Cieslinski LB, Burman M, Christensen SB, Torphy TJ (1995a) Inhibitors of phosphodiesterase IV (PDEIV) increase acid secretion in rabbit isolated gastric glands: Correlation between function and interaction with a high-affinity rolipram binding site. J Pharmacol Exp Ther 273:1396\u20131402","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR13_1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0022-3565(25)09531-X","volume":"273","author":"MS Barnette","year":"1995","unstructured":"Barnette MS, Manning CD, Cieslinski LB, Burman M, Christensen SB, Torphy TJ (1995b) The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity. J Pharmacol Exp Ther 273:674\u2013679","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR14_1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0006-2952(96)00053-6","volume":"51","author":"MS Barnette","year":"1996","unstructured":"Barnette MS, Bartus JO, Burman M, Christensen SB, Cieslinski LB, Esser KM, Prabhakar US, Rush JA, Torphy TJ (1996) Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding. Biochem Pharmacol 51:949\u2013956","journal-title":"Biochem Pharmacol"},{"key":"1_CR15_1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)37221-0","volume":"284","author":"MS Barnette","year":"1998","unstructured":"Barnette MS, Christensen SB, Essayan DM, Grous M, Prabhakar U, Rush JA, Kagey-Sobotka A, Torphy TS (1998) SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. J Pharmacol Exp Ther 284:420\u2013426","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR16_1","first-page":"1","volume":"22","author":"JA Beavo","year":"1988","unstructured":"Beavo JA (1988) Multiple isozymes of cyclic nucleotide phosphodisterase. Adv Sec Messengers Phosphoprotein Res 22:1\u201338","journal-title":"Adv Sec Messengers Phosphoprotein Res"},{"key":"1_CR17_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0026-895X(25)09714-7","volume":"46","author":"JA Beavo","year":"1994","unstructured":"Beavo JA, Conti M, Heaslip RJ (1994) Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399\u2013405","journal-title":"Mol Pharmacol"},{"key":"1_CR18_1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJM197812212992501","volume":"299","author":"JR Benotti","year":"1978","unstructured":"Benotti JR, Grossman W, Braunwald E, Davolos DD, Alousi A (1978) Hemodynamic assessment of amrinone. N Engl J Med 299:1373\u20131377","journal-title":"N Engl J Med"},{"key":"1_CR19_1","first-page":"A184","volume":"174","author":"R Beume","year":"1993","unstructured":"Beume R, Kilian U, Brand U, H\u00e4fner D, Eltze M, Flockerzi D (1993) The bronchospasmolytic effects of the PDEIII\/IV inhibitors B9004-70 and zardaverine \u2013 dependency on the route of administration in guinea pigs. Am Rev Respir Dis 174:A184","journal-title":"Am Rev Respir Dis"},{"key":"1_CR20_1","first-page":"P3845","volume":"662s","author":"S Boero","year":"2006","unstructured":"Boero S, Silvestri M, Sabatini F, Nachira A, Rossi GA (2006) Inhibition of human lung fibroblast functions by roflumilast N-oxide. Eur J Respir (Suppl) 662s:P3845, abstract","journal-title":"Eur J Respir (Suppl)"},{"key":"1_CR21_1","first-page":"47","volume":"8","author":"M Boolell","year":"1996","unstructured":"Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 8:47\u201352","journal-title":"Int J Impot Res"},{"key":"1_CR22_1","first-page":"938","volume":"2","author":"GS Brindley","year":"1982","unstructured":"Brindley GS (1982) Intracavernous injection of papaverine for erectile failure. Lancet 2:938","journal-title":"Lancet"},{"key":"1_CR23_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.1986.tb10191.x","volume":"87","author":"GS Brindley","year":"1986","unstructured":"Brindley GS (1986) Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol 87:495\u2013500","journal-title":"Br J Pharmacol"},{"key":"1_CR24_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(24)29538-0","volume":"297","author":"DS Bundschuh","year":"2001","unstructured":"Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R (2001) In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 297:280\u2013290","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR25_1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nbt.1598","volume":"28","author":"AB Burgin","year":"2010","unstructured":"Burgin AB, Magnusson OT, Singh J, Witte P, Staker BL, Bjornsson JM, Thorsteinsdottir M, Hrafnsdottir S, Hagen T, Kiselyov AS, Stewart LJ, Gurney ME (2010) Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. Nat Biotechnol 28:63\u201370","journal-title":"Nat Biotechnol"},{"key":"1_CR26_1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0160-5402(82)90071-7","volume":"8","author":"AM Burkman","year":"1982","unstructured":"Burkman AM (1982) Assessment of emetic and antiemetic activity. J Pharmacol Meth 8:165\u2013171","journal-title":"J Pharmacol Meth"},{"key":"1_CR27_1","first-page":"1","volume":"16","author":"RW Butcher","year":"1984","unstructured":"Butcher RW (1984) Phosphodiesterase after 20 years: an Introduction. Adv Cycl Nucl Protein Phos Res 16:1\u201312","journal-title":"Adv Cycl Nucl Protein Phos Res"},{"key":"1_CR28_1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","volume":"374","author":"PM Calverley","year":"2009","unstructured":"Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ, M2\u2013124 and M2\u2013125 study groups (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease. Two randomized clinical trials. Lancet 374:685\u201394","journal-title":"Lancet"},{"key":"1_CR29_1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/CS20000140","volume":"99","author":"SF Campbell","year":"2000","unstructured":"Campbell SF (2000) Science, art and drug discovery: a personal perspective. Clin Sci 99:255\u2013260","journal-title":"Clin Sci"},{"key":"1_CR30_1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","volume":"173","author":"AM Cantin","year":"2006","unstructured":"Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P (2006) Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 173:1139\u201344","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR31_1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0385-8146(98)00010-8","volume":"25","author":"A Cervin","year":"1998","unstructured":"Cervin A, Lindgren S (1998) The effect of selective phosphodiesterase inhibitors on mucociliary activity in the upper and lower airways in vitro. Auris Nasus Larynx 25:269\u201376","journal-title":"Auris Nasus Larynx"},{"key":"1_CR32_1","first-page":"282","volume":"39","author":"IC Chikanza","year":"1996","unstructured":"Chikanza IC, Jawed SJ, Blake DR, Perrot S, Menkes CI, Barnes CG, Perry JD, Wright MG (1996) Treatment of patients with rheumathoid arthritis with RP73401 phosphodiesterase type IV inhibitor. Arthritis Rheum 39:282","journal-title":"Arthritis Rheum"},{"key":"1_CR33_1","volume-title":"Phosphodiesterase inhibitors","author":"SB Christensen","year":"1996","unstructured":"Christensen SB, DeWolf WE, Ryan MD, Torphy TJ (1996) Molecular aspects of inhibitor interaction with PDE4. In: Schudt C, Dent G, Rabe KF (eds) Phosphodiesterase inhibitors. Acedemic, London"},{"key":"1_CR34_1","doi-asserted-by":"publisher","first-page":"L612","DOI":"10.1152\/ajplung.00390.2007","volume":"294","author":"A Churg","year":"2008","unstructured":"Churg A, Cosio M, Wright JL (2008) Mechanism of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol 294:L612\u2013L631","journal-title":"Am J Physiol Lung Cell Mol"},{"key":"1_CR35_1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0140-6736(83)90235-0","volume":"322","author":"DW Cockroft","year":"1983","unstructured":"Cockroft DW (1983) Mechanism of perennial allergic asthma. Lancet 322:253\u2013256","journal-title":"Lancet"},{"key":"1_CR36_1","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/lary.20223","volume":"119","author":"NA Cohen","year":"2009","unstructured":"Cohen NA, Zhang S, Sharp DB, Tamashiro E, Chen B, Sorscher EJ, Woodworth BA (2009) Cigarette smoke condensate inhibits transepithelial chloride transport and ciliary beat frequency. Laryngoscope 119:2269\u20132274","journal-title":"Laryngoscope"},{"key":"1_CR37_1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0140-6736(01)05481-2","volume":"358","author":"CH Compton","year":"2001","unstructured":"Compton CH, Gubb J, Nieman R, Edelson J, Ohad A, Bakst A, Ayres JG, Creemers JP, Schultze-Werninghaus G, Brambilla C, Barnes NC (2001) Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 358:265\u2013270","journal-title":"Lancet"},{"key":"1_CR38_1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"M Conti","year":"2007","unstructured":"Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481\u2013511","journal-title":"Annu Rev Biochem"},{"key":"1_CR39_1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1476-5381.1993.tb12841.x","volume":"108","author":"J Cortijo","year":"1993","unstructured":"Cortijo J, Bou J, Cardelus I, Llenas J, Morcillo E, Gristwood RW (1993) Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus. Br J Pharmacol 108:562\u2013568","journal-title":"Br J Pharmacol"},{"key":"1_CR40_1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","volume":"156","author":"J Cortijo","year":"2009","unstructured":"Cortijo J, Iranzo A, Milara X, Mata M, Cerd\u00e1-Nicol\u00e1s M, Ruiz-Saur\u00ed A, Tenor H, Hatzelmann A, Morcillo EJ (2009) Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury. Br J Pharmacol 156:534\u2013544","journal-title":"Br J Pharmacol"},{"key":"1_CR41_1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0014-2999(88)90453-0","volume":"148","author":"AJ Coyle","year":"1988","unstructured":"Coyle AJ, Urwin SJ, Page CP, Touvay C, Villain B, Braquet P (1988) The effect of selective PAF antagonist BN52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. Eur J Pharmacol 148:51\u201358","journal-title":"Eur J Pharmacol"},{"key":"1_CR42_1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0091-6749(85)90057-0","volume":"75","author":"MJ Cushley","year":"1985","unstructured":"Cushley MJ, Holgate ST (1985) Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release. J Allergy Clin Immunol 75:272\u2013278","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR43_1","first-page":"A878","volume":"141","author":"G Dent","year":"1990","unstructured":"Dent G, Rabe KF, Giembycz MA (1990) Inhibition of eosinophil respiratory burst activity by type IV- but not by type III-selective phosphodiesterase inhibitors. A Rev Respir Dis 141:A878","journal-title":"A Rev Respir Dis"},{"key":"1_CR44_1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1476-5381.1991.tb09790.x","volume":"103","author":"G Dent","year":"1991","unstructured":"Dent G, Giembycz MA, Rabe KF, Barnes PJ (1991) Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by \u201ctype IV\u201d-selective PDE inhibitors. Br J Pharmacol 103:1339\u20131346","journal-title":"Br J Pharmacol"},{"key":"1_CR45_1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/pupt.1998.0115","volume":"11","author":"G Dent","year":"1998","unstructured":"Dent G, White SR, Tenor H, Bodtke K, Schudt C, Leff AR, Magnussen H, Rabe KF (1998) Cyclic nucleotide phosphodiesterase in human bronchial epithelial cells: characterization of isoenzymes and functional effects of PDE inhibitors. Pulm Pharmacol Ther 11:47\u201356","journal-title":"Pulm Pharmacol Ther"},{"key":"1_CR46_1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1161\/CIRCRESAHA.109.196592","volume":"104","author":"I Diebold","year":"2009","unstructured":"Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, G\u00f6rlach A (2009) Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res 104:1169\u201377","journal-title":"Circ Res"},{"key":"1_CR47_1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cellsig.2004.07.007","volume":"17","author":"T Dunkern","year":"2005","unstructured":"Dunkern T, Hatzelmann A (2005) The effect of sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Cell Signal 17:331\u2013339","journal-title":"Cell Signal"},{"key":"1_CR48_1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2007.06.036","volume":"572","author":"TR Dunkern","year":"2007","unstructured":"Dunkern TR, Feurstein D, Rossi GA, Sabatini F, Hatzelmann A (2007) Inhibition of TGF-\u00df induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. Eur J Pharmacol 572:12\u201322","journal-title":"Eur J Pharmacol"},{"key":"1_CR49_1","first-page":"169","volume":"94","author":"R Engelstaetter","year":"2005","unstructured":"Engelstaetter R, Wingertzahn M, Schmid-Wirlitsch C, Bredenbr\u00f6ker D, Leichtl S, Wurst W (2005) Roflumilast, an investigational, oral, once daily phosphodiesterase 4 inhibitor, did not exhibit acute bronchodilatory activity after a single dose. Ann Allergy Asthma Immunol 94:169","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1_CR50_1","first-page":"687","volume":"264","author":"PJ England","year":"1987","unstructured":"England PJ, Shahid M (1987) Effects of forskolin on contractile responses and protein phosphorylation in the isolated perfused heart. Br J Pharmacol 264:687\u2013695","journal-title":"Br J Pharmacol"},{"key":"1_CR52_1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0140-6736(09)61252-6","volume":"374","author":"LM Fabbri","year":"2009","unstructured":"Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF (2009) M2-127 and M2-128 study groups. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with long acting bronchodilators: two randomised clinical trials. Lancet 374:695\u2013703","journal-title":"Lancet"},{"key":"1_CR53_1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0024-3205(78)90083-8","volume":"22","author":"AE Farah","year":"1978","unstructured":"Farah AE, Alousi AA (1978) New cardiotonic agents: a search for digitalis substitute. Life sci 22:1139\u20131148","journal-title":"Life sci"},{"key":"1_CR54_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0025-7125(16)33056-5","volume":"51","author":"GF Filley","year":"1967","unstructured":"Filley GF (1967) Emphysema and chronic bronchitis: clinical manifestations and their physiologic significance. Med Clin North Am 51:283\u2013292","journal-title":"Med Clin North Am"},{"key":"1_CR55_1","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/cber.189502803156","volume":"28","author":"E Fischer","year":"1895","unstructured":"Fischer E, Ach L (1895) Synthese des Caffeins. Berichte der deutschen Gesellschaft 28:3135","journal-title":"Berichte der deutschen Gesellschaft"},{"key":"1_CR56_1","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/0006-2952(93)90219-M","volume":"12","author":"W Fischer","year":"1993","unstructured":"Fischer W, Schudt C, Wendel A (1993) Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem Pharmacol 12:2399\u20132404","journal-title":"Biochem Pharmacol"},{"key":"1_CR57_1","doi-asserted-by":"publisher","first-page":"A91","DOI":"10.1164\/rccm.2211008","volume":"167","author":"MF Fitzgerald","year":"2003","unstructured":"Fitzgerald MF, Spicer D, Henning R (2003) Efficacy of the PDE4 inhibitor Bay 19-8004 and a steroid in tobacco smoke-induced models of pulmonary inflammation in the mouse. Am J Respir Crit Care Med 167:A91","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR58_1","first-page":"P3850","volume":"663s","author":"MF Fitzgerald","year":"2006","unstructured":"Fitzgerald MF, Spicer D, McAulay AE, Wollin L, Beume R (2006) Roflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigs. Eur Respir J Suppl 663s:P3850, abstract","journal-title":"Eur Respir J Suppl"},{"key":"1_CR59_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1992.tb05658.x","volume":"34","author":"RW Foster","year":"1992","unstructured":"Foster RW, Rakshi K, Carpenter JR, Small RC (1992) Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volonteers during methacholine challenge test. Br J Clin Pharmacol 34:527\u2013534","journal-title":"Br J Clin Pharmacol"},{"key":"1_CR60_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0021-9258(19)86221-X","volume":"255","author":"SH Francis","year":"1980","unstructured":"Francis SH, Lincoln TM, Corbin JD (1980) Characterization of a novel cGMP binding protein from rat lung. J Biol Chem 255:620\u2013626","journal-title":"J Biol Chem"},{"key":"1_CR61_1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1476-5381.1981.tb08748.x","volume":"73","author":"N Frossard","year":"1981","unstructured":"Frossard N, Landry Y, Pauli G, Ruckstuhl M (1981) Effects of cyclic AMP- and cyclic GMP-phosphodiesterase inhibitors on immunological release of histamine and lung contraction. Br J Pharmacol 73:933\u2013938","journal-title":"Br J Pharmacol"},{"key":"1_CR62_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1165\/ajrcmb.20.2.3140","volume":"20","author":"M Fuhrmann","year":"1999","unstructured":"Fuhrmann M, Jahn HU, Seybold J, Neurohr C, Barnes PJ, Hippenstiel S, Kraemer HJ, Suttorp N (1999) Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol 20:292\u2013302","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1_CR63_1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.bjp.0701124","volume":"121","author":"F Gantner","year":"1997","unstructured":"Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A (1997a) In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-\u03b1 release by PDE inhibitors. Br J Pharmacol 121:221\u2013231","journal-title":"Br J Pharmacol"},{"key":"1_CR64_1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0091-6749(97)70146-5","volume":"100","author":"F Gantner","year":"1997","unstructured":"Gantner F, Tenor H, Gekeler V, Schudt C, Wendel A, Hatzelmann A (1997b) Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. J Allergy Clin Immunol 100:527\u2013537","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR65_1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1006\/pupt.1999.0220","volume":"12","author":"F Gantner","year":"1999","unstructured":"Gantner F, Schudt C, Wendel A, Hatzelmann A (1999) Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC functions. Pulm Pharmacol Ther 12:377\u2013386","journal-title":"Pulm Pharmacol Ther"},{"key":"1_CR66_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","volume":"136","author":"HA Ghofrani","year":"2002","unstructured":"Ghofrani HA, Wiedemann R, Rose F, Olschewki H, Schermuly RT, Weissmann N, Seeger W, Grimminger F (2002a) Combination therapy with oral sildenafil and inhaled ileprost for severe pulmonary hypertension. Ann Intern Med 136:515\u2013522","journal-title":"Ann Intern Med"},{"key":"1_CR67_1","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1097\/00003246-200211000-00014","volume":"30","author":"HA Ghofrani","year":"2002","unstructured":"Ghofrani HA, Rose F, Schermuly RT, Olschewski H, Wiedemann R, Weissmann N, Schudt C, Tenor H, Seeger W, Grimminger F (2002b) Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension. Crit Care Med 30:2489\u20132492","journal-title":"Crit Care Med"},{"key":"1_CR68_1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Rev 5:689\u2013702","journal-title":"Nature Rev"},{"key":"1_CR69_1","first-page":"147","volume":"4","author":"MA Giembycz","year":"2010","unstructured":"Giembycz MA, Field KF (2010) Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. Drug Des Dev Ther 4:147\u2013158","journal-title":"Drug Des Dev Ther"},{"key":"1_CR70_1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","volume":"118","author":"MA Giembycz","year":"1996","unstructured":"Giembycz MA, Corrigan CJ, Seybold J, Newton R, Barnes PF (1996) Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T- lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol 118:1945\u20131958","journal-title":"Br J Pharmacol"},{"key":"1_CR71_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1476-5381.1986.tb10150.x","volume":"87","author":"RG Goldie","year":"1986","unstructured":"Goldie RG, Papadimitriou JM, Paterson JW, Rigby PJ, Self HM, Spina D (1986) Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol 87:5\u201314","journal-title":"Br J Pharmacol"},{"key":"1_CR72_1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1001\/jama.1937.02780470034009","volume":"109","author":"JA Greene","year":"1937","unstructured":"Greene JA, Paul WD (1937) The action of theophylline with ethylenediamine on intrathecal and venous pressure in cardiac failure and on bronchial obstruction in cardiac failure an bronchial asthma. J Am Med Assoc 109:1712","journal-title":"J Am Med Assoc"},{"key":"1_CR73_1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1152\/jappl.1995.78.4.1509","volume":"78","author":"F Grimminger","year":"1995","unstructured":"Grimminger F, Spriesterbach R, Weissmann N, Walmrath D, Seeger W (1995) Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J Appl Physiol 78:1509\u20131515","journal-title":"J Appl Physiol"},{"key":"1_CR74_1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1094-5539(02)00172-4","volume":"16","author":"DC Grootendorst","year":"2003","unstructured":"Grootendorst DC, Gauw SA, Baan R, Kelly J, Murdoch RD, Sterk PJ, Rabe KF (2003) Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast \/15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease? Pulm Pharmacol Ther 16:115\u2013129","journal-title":"Pulm Pharmacol Ther"},{"key":"1_CR75_1","first-page":"613","volume":"24","author":"R Grueter","year":"1910","unstructured":"Grueter R (1910) \u00dcber leicht l\u00f6sliche Verbindungen des Theophyllins. Therapeutische Monatshefte 24:613","journal-title":"Therapeutische Monatshefte"},{"key":"1_CR76_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1476-5381.1972.tb08135.x","volume":"46","author":"TC Hamilton","year":"1972","unstructured":"Hamilton TC (1972) The effects of some phosphodiesterase inhibitors on the conductance of the perfused vascular beds of the chloralosed cat. Br J Pharmacol 46:386\u2013394","journal-title":"Br J Pharmacol"},{"key":"1_CR77_1","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/sj.bjp.0703961","volume":"132","author":"JP Hannon","year":"2001","unstructured":"Hannon JP, Tigani B, Williams I, Mazzoni L, Fozard JR (2001) Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br J Pharmacol 132:1509\u20131523","journal-title":"Br J Pharmacol"},{"key":"1_CR78_1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0091-6749(89)90033-X","volume":"83","author":"FE Hargreave","year":"1989","unstructured":"Hargreave FE (1989) Late-phase asthmatic responses and airway inflammation. J Allergy Clin Immunol 83:525\u2013527","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR79_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-3565(25)20704-2","volume":"251","author":"AL Harris","year":"1989","unstructured":"Harris AL, Conell MJ, Ferguson EW, Wallace AM, Gordon RJ, Pagani ED, Silver PJ (1989) Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J Pharmacol Exp Ther 251:199\u2013206","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR80_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","volume":"297","author":"A Hatzelmann","year":"2001","unstructured":"Hatzelmann A, Schudt C (2001) Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J Pharmacol Exp Ther 297:267\u2013279","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR81_1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1476-5381.1995.tb13278.x","volume":"114","author":"A Hatzelmann","year":"1995","unstructured":"Hatzelmann A, Tenor H, Schudt C (1995) Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br J Pharmacol 114:821\u2013831","journal-title":"Br J Pharmacol"},{"key":"1_CR82_1","volume-title":"Phosphodiesterase inhibitors","author":"A Hatzelmann","year":"1996","unstructured":"Hatzelmann A, Engelst\u00e4tter R, Morley J, Mazzoni L (1996a) Enzymatic and functional aspects of dual-selective PDE3\/4 inhibitors. In: Schudt C, Dent G, Rabe KF (eds) Phosphodiesterase inhibitors. Academic, London"},{"key":"1_CR83_1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/1056-8719(96)00005-6","volume":"35","author":"A Hatzelmann","year":"1996","unstructured":"Hatzelmann A, Haefner D, Beume R, Schudt C (1996b) Automatic leukocyte differentiation in bronchoalveolar lavage fluid of guinea pigs ad Brown-Norway rats. J Pharmacol Toxicol Meth 35:91\u201399","journal-title":"J Pharmacol Toxicol Meth"},{"issue":"4","key":"1_CR84_1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","volume":"23","author":"A Hatzelmann","year":"2010","unstructured":"Hatzelmann A, Morcillo E, Lungarella G, Adnot S, Sanjar S, Beume R, Schudt C, Tenor H (2010) The preclinical pharmacology of roflumilast \u2013 a selective, oral phosphodiesterase inhibitor in development for chronic obstructive pulmonary disease. Pulm Pharmacol Ther 23(4):235\u2013256","journal-title":"Pulm Pharmacol Ther"},{"key":"1_CR86_1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.RES.43.4.592","volume":"43","author":"P Hedqvist","year":"1978","unstructured":"Hedqvist P, Fredholm BB, Olundh S (1978) Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 43:592\u2013598","journal-title":"Circ Res"},{"key":"1_CR87_1","first-page":"135","volume":"23","author":"GR Hermann","year":"1937","unstructured":"Hermann GR, Aynesworth MB, Martin J (1937) Successful treatment of persistent extreme dyspnea, \u201cstatus asthmaticus\u201d \u2013 use of theophylline ethylene diamine (aminophylline, U.S.P.) intravenously. J Lab Clin Med 23:135","journal-title":"J Lab Clin Med"},{"key":"1_CR88_1","first-page":"485","volume":"429","author":"H Hidaka","year":"1976","unstructured":"Hidaka H, Asano T (1976) Human platelet 3\u2032:5\u2032-cyclic nucleotide phosphodiesterase. Biochem Biophys Acta 429:485\u2013497","journal-title":"Biochem Biophys Acta"},{"key":"1_CR89_1","first-page":"615","volume":"13","author":"S Hirsch","year":"1920","unstructured":"Hirsch S (1922) Klinischer und experimenteller Beitrag zur krampfl\u00f6senden Wirkung der Purinderivate. Klinische Wochenschrift 1:615\u2013618","journal-title":"Klinische Wochenschrift"},{"key":"1_CR90_1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1523-1747.ep12524844","volume":"87","author":"CA Holden","year":"1986","unstructured":"Holden CA, Chan SC, Hanifin JM (1986) Monocyte localization of elevated cAMP phosphodiesterase activity in atopic dermatitis. J Invest Dermatol 87:372\u2013376","journal-title":"J Invest Dermatol"},{"key":"1_CR91_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00508835","volume":"318","author":"P Honerj\u00e4ger","year":"1981","unstructured":"Honerj\u00e4ger P, Sch\u00e4fer-Korting M, Reiter M (1981) Involvement of cyclic AMP in direct inotropic action of amrinone. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 318:112\u2013120","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1_CR92_1","first-page":"23","volume":"38","author":"R Horowski","year":"1985","unstructured":"Horowski R, Sastre-Y-Hernandez M (1985) Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports. Curr Ther Res 38:23\u201329","journal-title":"Curr Ther Res"},{"key":"1_CR93_1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0006-291X(90)92168-Y","volume":"170","author":"LJ Ignarro","year":"1990","unstructured":"Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J (1990) Nitric oxide and cyclic GMP formation upon a electric fields stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Comm 170:843\u2013850","journal-title":"Biochem Biophys Res Comm"},{"key":"1_CR94_1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1124\/jpet.108.148742","volume":"330","author":"M Izikki","year":"2009","unstructured":"Izikki M, Raffestin B, Klar J, Hatzelmann J, Marx D, Tenor H, Zadigue P, Adnot S, Eddahibi S (2009) Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in rats. J Pharmacol Exp Ther 330:54\u201362","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR95_1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pupt.2004.10.001","volume":"18","author":"NA Jones","year":"2005","unstructured":"Jones NA, Boswell-Smith V, Lever R, Page CP (2005) The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro. Pulm Pharmacol Ther 18:93\u2013101","journal-title":"Pulm Pharmacol Ther"},{"key":"1_CR96_1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1084\/jem.136.3.556","volume":"136","author":"M Kaliner","year":"1972","unstructured":"Kaliner M, Orange R, Austen F (1972) Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. J Exp Med 136:556\u2013566","journal-title":"J Exp Med"},{"key":"1_CR97_1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0167-5699(88)91220-0","volume":"9","author":"GM Kammer","year":"1988","unstructured":"Kammer GM (1988) The adenylate cyclise-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9:222\u2013229","journal-title":"Immunol Today"},{"key":"1_CR98_1","first-page":"23","volume":"3","author":"S Katsuki","year":"1977","unstructured":"Katsuki S, Arnold W, Mittal C, Murad F (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cycl Nucl Res 3:23\u201335","journal-title":"J Cycl Nucl Res"},{"key":"1_CR99_1","first-page":"S63","volume":"135","author":"AB Kay","year":"1987","unstructured":"Kay AB (1987) Inflammatory cells in acute and chronic asthma. Am Rev Respir Dis 135:S63\u201366","journal-title":"Am Rev Respir Dis"},{"key":"1_CR100_1","first-page":"331","volume":"28","author":"U Kilian","year":"1989","unstructured":"Kilian U, Beume EM, Schudt C (1989) Is phosphodiesterase inhibition a relevant bronchospasmolytic principle? Agents Actions (Suppl) 28:331\u2013348","journal-title":"Agents Actions (Suppl)"},{"key":"1_CR101_1","first-page":"3258","volume":"544s","author":"J Klar","year":"2007","unstructured":"Klar J, Sabatini F, Schatton E, Burgbacher B, Rossi GA, Hatzelmann A, Tenor H (2007) Roflumilast N-oxide reduces human fibroblast function. Eur Respir J (Suppl) 544s:3258, abstract","journal-title":"Eur Respir J (Suppl)"},{"key":"1_CR102_1","first-page":"200","volume":"36","author":"J Kleine-Tebbe","year":"1992","unstructured":"Kleine-Tebbe J, Wicht L, Gagne H, Friese A, Schunack W, Schudt C, Kunkel G (1992) Inhibition of IgE.mediated histamine release from human peripheral leukocytes by selective phosphodiesterase inhibitors. Agents Actions 36:200\u2013206","journal-title":"Agents Actions"},{"key":"1_CR103_1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1464-410X.2005.05797.x","volume":"95","author":"L Klotz","year":"2005","unstructured":"Klotz L (2005) How (not) to communicate scientific information: a memoir of the famous Brindley lecture. Br J Urol 95:956\u2013957","journal-title":"Br J Urol"},{"key":"1_CR104_1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF00300254","volume":"20","author":"HH Knispel","year":"1992","unstructured":"Knispel HH, Goessl C, Beckmann R (1992) Nitric oxide mediate relaxation in rabbit and human corpus cavernosum smooth muscle. Urol Res 20:253\u2013257","journal-title":"Urol Res"},{"key":"1_CR105_1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1165\/ajrcmb.26.6.4743","volume":"26","author":"T Kohyama","year":"2002","unstructured":"Kohyama T, Liu X, Wen FQ, Zhu YK, Wang H, Kim HJ, Takizawa H, Cieslinski LB, Barnette MS, Rennard SI (2002) PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels. Am J Respir Cell Mol Biol 26:694\u2013701","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1_CR106_1","doi-asserted-by":"publisher","first-page":"L894","DOI":"10.1152\/ajplung.00376.2004","volume":"288","author":"JL Kreindler","year":"2005","unstructured":"Kreindler JL, Jackson AD, Kemp PA, Bridges RJ, Danahay H (2005) Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am J Physiol Lung Cell Mol Physiol 288:L894\u2013902","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1_CR107_1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00500277","volume":"310","author":"WR Kukovetz","year":"1979","unstructured":"Kukovetz WR, Holzmann S, Wurm A, P\u00f6ch G (1979) Evidence for cGMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 310:129\u2013138","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1_CR108_1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/157489007782418991","volume":"2","author":"M Kumar","year":"2007","unstructured":"Kumar M, Bhattacharya V (2007) Cilostazol: a new drug in the treatment intermittent claudication. Recent Pat Cardiovasc Drug Discov 2:181\u2013185","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"1_CR109_1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1124\/jpet.103.053819","volume":"307","author":"RK Kumar","year":"2003","unstructured":"Kumar RK, Herbert C, Thomas PS, Wollin L, Beume R, Yang M, Webb DC, Foster PS (2003) Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther 307:349\u2013355","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR110_1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0167-4889(85)90076-X","volume":"846","author":"PM Lad","year":"1985","unstructured":"Lad PM, Goldberg BJ, Smiley PA, Olson CV (1985) Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. Biochem Biophys Acta 846:286\u2013295","journal-title":"Biochem Biophys Acta"},{"key":"1_CR111_1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/BF01812150","volume":"61","author":"O Langendorff","year":"1895","unstructured":"Langendorff O (1895) Untersuchungen am \u00fcberlebenden S\u00e4ugethierherzen. Arch ges Physiol 61:291\u2013332","journal-title":"Arch ges Physiol"},{"key":"1_CR112_1","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1183\/09031936.06.00076905","volume":"27","author":"O Leclerc","year":"2006","unstructured":"Leclerc O, Lagente V, Planquois JM, Bethelier C, Artola M, Eichholtz T, Bertrand CP, Schmidlin F (2006) Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice. Eur Respir J 27:1102\u20131109","journal-title":"Eur Respir J"},{"key":"1_CR113_1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1164\/rccm.200501-041OC","volume":"172","author":"J-H Lee","year":"2005","unstructured":"Lee J-H, Lee D-S, Kim E-K, Oh Y-M, Shim T-S, Kim S-E, Lee Y-S, Lee S-D (2005) Simvastatin inhibits cigarette smoking-induced ephysema and pulmonary hypertension in rat lungs. Am J Respir Crit Care Med 172:987\u2013983","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR114_1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1378\/chest.91.5.662","volume":"91","author":"M Leeman","year":"1987","unstructured":"Leeman M, Lejeune P, Melot C, Naelje R (1987) Reduction in pulmonary hypertension and in airway resistances by enoximone (NDL 17, 043) in decompensated COPD. Chest 91:662","journal-title":"Chest"},{"key":"1_CR115_1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.CIR.59.6.1098","volume":"59","author":"TH LeJemtel","year":"1979","unstructured":"LeJemtel TH, Keung E, Sonnenblick EH, Ribner HS, Matsumoto M, Davis R, Schwartz W, Alousi AA, Davolos D (1979) Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1098\u20131104","journal-title":"Circulation"},{"key":"1_CR116_1","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.161.3845.982","volume":"161","author":"ML Liechtenstein","year":"1968","unstructured":"Liechtenstein ML, Margolis S (1968) Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science 161:982\u2013983","journal-title":"Science"},{"key":"1_CR117_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0026-895X(25)14282-X","volume":"23","author":"KL Lorenz","year":"1982","unstructured":"Lorenz KL, Wells JN (1982) Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors. Mol Pharmacol 23:424\u2013430","journal-title":"Mol Pharmacol"},{"key":"1_CR118_1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/thx.53.5.419","volume":"5","author":"J L\u00f6tvall","year":"1998","unstructured":"L\u00f6tvall J, Inman M, O\u2019Byrne P (1998) Measurements of airway hyperresponsiveness: new considerations. Thorax 5:419\u2013424","journal-title":"Thorax"},{"key":"1_CR119_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3565(25)09383-8","volume":"18","author":"DI Macht","year":"1921","unstructured":"Macht DI, Ting GC (1921) A study of antispasmodic drugs in the bronchus. J Pharmacol Exp Ther 18:373\u2013398","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR120_1","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1073\/pnas.83.17.6660","volume":"83","author":"CH MacPhee","year":"1986","unstructured":"MacPhee CH, Harrison SA, Beavo JA (1986) Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents. Proc Natl Acad Sci 83:6660\u20136663","journal-title":"Proc Natl Acad Sci"},{"key":"1_CR121_1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF01681793","volume":"102","author":"R Magnus","year":"1904","unstructured":"Magnus R (1904) Versuche am \u00fcberlebenden D\u00fcnndarm von S\u00e4ugethieren. Pfl\u00fcger\u2019s Arch 102:123\u2013151","journal-title":"Pfl\u00fcger\u2019s Arch"},{"key":"1_CR122_1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0006-2952(87)90377-7","volume":"36","author":"G Marone","year":"1987","unstructured":"Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A, Formisano S (1987) Inhibition of IgE- mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem Pharmacol 36:13\u201320","journal-title":"Biochem Pharmacol"},{"key":"1_CR123_1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.200411-1549OC","volume":"172","author":"PA Martorana","year":"2005","unstructured":"Martorana PA, Beume R, Lucattelli M, Wollin L, Lungarella G (2005) Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke. Am J Respir Crit Care Med 172:848\u2013853","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR124_1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2466-8-17","volume":"8","author":"PA Martorana","year":"2008","unstructured":"Martorana PA, Lunghi B, Lucattelli M, de Cunto G, Beume R, Lungarella G (2008) Effect of roflumilast on inflammatory cells in lungs of cigarette smoke-exposed mice. BMC Pulm Med 8:17\u201326","journal-title":"BMC Pulm Med"},{"key":"1_CR125_1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/thx.2004.025692","volume":"60","author":"M Mata","year":"2005","unstructured":"Mata M, Sarri\u00e1 B, Buenestado A, Cortijo J, Cerd\u00e1 M, Morcillo EJ (2005) Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells. Thorax 60:144\u201352","journal-title":"Thorax"},{"key":"1_CR126_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0026-895X(25)10974-7","volume":"37","author":"DH Maurice","year":"1990","unstructured":"Maurice DH, Haslam RJ (1990) Molecular basis of synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 37:671\u2013681","journal-title":"Mol Pharmacol"},{"key":"1_CR127_1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2222.1974.tb01377.x","volume":"4","author":"CD May","year":"1974","unstructured":"May CD (1974) History of the introduction of theophylline into the treatment of asthma. Clin Allergy 4:211\u2013217","journal-title":"Clin Allergy"},{"key":"1_CR128_1","first-page":"P3651","volume":"639s","author":"J Milara","year":"2008","unstructured":"Milara J, Cortijo J, Armengot M, Banuls P, Gabarda E, Morcillo E (2008a) Effect of roflumilast, a PDE4 inhibitor on ciliary beat frequency in human nasal epithelial cells. Eur Respir J Suppl 639s:P3651","journal-title":"Eur Respir J Suppl"},{"key":"1_CR129_1","first-page":"P3648","volume":"639s","author":"J Milara","year":"2008","unstructured":"Milara J, Cortijo J, Mata M, Donet E, Mauricio M, Morcillo EJ (2008b) The PDE4 inhibitor roflumilast N-oxide partly reversed TGF\u00df1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells. Eur Respir J (Suppl) 639s:P3648, abstract","journal-title":"Eur Respir J (Suppl)"},{"key":"1_CR130_1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(84)91567-8","volume":"2","author":"J Morley","year":"1984","unstructured":"Morley J, Sanjar S, Page CP (1984) Platelet activation as a basis for asthma exacerbation. Lancet 2:1142\u20131144","journal-title":"Lancet"},{"key":"1_CR131_1","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"JL Murray","year":"1997","unstructured":"Murray JL, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: global burden of disease study. Lancet 349:1498\u20131504","journal-title":"Lancet"},{"key":"1_CR133_1","unstructured":"Muzaffar S, Shukla N, Angelini GD, Jeremy JY (2008). Roflumilast N-oxide inhibits NADPH oxidase expression and activity in human pulmonary artery smooth muscle cells; Proc Br Pharmacol Soc 027P, (abstract)."},{"key":"1_CR134_1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/j.1476-5381.1996.tb15628.x","volume":"118","author":"E Naline","year":"1996","unstructured":"Naline E, Qian Y, Advenier C, Raeburn D, Karlsson J-A (1996) Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle. Br J Pharmacol 118:1939\u20131944","journal-title":"Br J Pharmacol"},{"key":"1_CR135_1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1476-5381.1989.tb12029.x","volume":"97","author":"CD Nicholson","year":"1989","unstructured":"Nicholson CD, Jackman SA, Wilke R (1989) The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the re-uptake site. Br J Pharmacol 97:889\u2013897","journal-title":"Br J Pharmacol"},{"key":"1_CR136_1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0165-6147(91)90484-A","volume":"12","author":"CD Nicholson","year":"1991","unstructured":"Nicholson CD, Challiss RAJ, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12:19\u201327","journal-title":"Trends Pharmacol Sci"},{"key":"1_CR137_1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0091-6749(05)80186-1","volume":"86","author":"CP Nielson","year":"1990","unstructured":"Nielson CP, Vestal RE, RJ S, Heaslip R (1990) Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Alllergy Clin Immunol 86:801\u2013808","journal-title":"J Alllergy Clin Immunol"},{"key":"1_CR138_1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ddr.430140307","volume":"14","author":"M O\u2019Connolly","year":"1988","unstructured":"O\u2019Connolly M, Dierdorf D, Greb WH, Mayer M-ER, Wolf D (1988) Efficacy of denbuffylline in patients with multi-infarct dementia. Dru Dev Res 14:195\u2013198","journal-title":"Dru Dev Res"},{"key":"1_CR139_1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.rmed.2004.02.020","volume":"98","author":"K Ohta","year":"2004","unstructured":"Ohta K, Fukuchi Y, Grouse L, Mizutani R, Rabe KF, Rennard SI, Zhong N-S (2004) A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med 98:1016\u20131024","journal-title":"Respir Med"},{"key":"1_CR140_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1084\/jem.134.3.136","volume":"134","author":"RO Orange","year":"1971","unstructured":"Orange RO, Austen WG, Austen KF (1971) Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. J Exp Med 134:136\u2013148","journal-title":"J Exp Med"},{"key":"1_CR141_1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","volume":"3325","author":"M Packer","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tendon PK, DeMets DL (1991) Effect of oral milrinone on mortality in severe heart failure. N Engl J Med 3325:1468\u20131475","journal-title":"N Engl J Med"},{"key":"1_CR142_1","unstructured":"Pedemonte N, Galietta L (2008). Stimulation of CFTR-dependent chloride secretion by roflumilast. Eur Respir J Suppl 644s:P3672."},{"key":"1_CR143_1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/thx.40.12.881","volume":"40","author":"CG Persson","year":"1985","unstructured":"Persson CG (1985) On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax 40:881\u2013886","journal-title":"Thorax"},{"key":"1_CR144_1","doi-asserted-by":"crossref","first-page":"609-","DOI":"10.1016\/S0022-3565(25)03972-2","volume":"3","author":"JD Pilcher","year":"1912","unstructured":"Pilcher JD (1912) The action of caffein on the mammalian heart. J Pharmacol Exp Med 3:609-\u2013624","journal-title":"J Pharmacol Exp Med"},{"key":"1_CR145_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-3565(25)08253-9","volume":"5","author":"OH Plant","year":"1914","unstructured":"Plant OH (1914) A note of the efficiency of the Knowlton-Starling isolated heart-lung preparation for testing the action of drugs. J Pharmacol Exp Med 5:603\u2013614","journal-title":"J Pharmacol Exp Med"},{"key":"1_CR146_1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0024-3205(71)90086-5","volume":"10","author":"G Poech","year":"1971","unstructured":"Poech G, Kukovetz WR (1971) Papaverine \u2013 induced inhibition of phosphodiesterase activity in various mammalian tissues. Life sci 10:133\u2013144","journal-title":"Life sci"},{"key":"1_CR147_1","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1016\/0006-2952(82)90618-9","volume":"21","author":"JB Polson","year":"1982","unstructured":"Polson JB, Krzanowski JJ, Szentivani A (1982) Inhibition of a high cyclic AMP phosphodiesterase and relaxation of canine tacheal smooth muscle. Biochem Pharmacol 21:3403\u20133406","journal-title":"Biochem Pharmacol"},{"key":"1_CR148_1","first-page":"L458","volume":"264","author":"KF Rabe","year":"1993","unstructured":"Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen (1993) Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization. Am J Physiol 264:L458\u2013L464","journal-title":"Am J Physiol"},{"key":"1_CR149_1","doi-asserted-by":"crossref","first-page":"L536","DOI":"10.1152\/ajpcell.1994.266.2.C536","volume":"266","author":"KF Rabe","year":"1994","unstructured":"Rabe KF, Tenor H, Dent G, Schudt C, Nakashima M, Magnussen H (1994) Identification of PDE isoenzymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 266:L536\u2013L543","journal-title":"Am J Physiol"},{"key":"1_CR151_1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0021-9258(19)77422-5","volume":"232","author":"TW Rall","year":"1958","unstructured":"Rall TW, Sutherland EW (1958) Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232:1065\u20131091","journal-title":"J Biol Chem"},{"key":"1_CR152_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3565(25)26490-4","volume":"139","author":"TW Rall","year":"1963","unstructured":"Rall TW, West TC (1963) The potentiation of cardiac inotropic responses to norepinephrine by theophylline. J Pharmacol Exp Ther 139:269\u2013274","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR153_1","volume-title":"Von Coffein zum Furosemid. Entdeckung, Erforschung und Entwicklung der Diuretika im 20. Jahrhundert","author":"S Rau","year":"2001","unstructured":"Rau S (2001) Von Coffein zum Furosemid. Entdeckung, Erforschung und Entwicklung der Diuretika im 20. Jahrhundert. Peter Lang, Frankfurt aM"},{"key":"1_CR154_1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1476-5381.1994.tb17156.x","volume":"113","author":"D Reaburn","year":"1994","unstructured":"Reaburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, Karlsson J-A (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 113:1423\u20131431","journal-title":"Br J Pharmacol"},{"key":"1_CR155_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2410535","volume":"241","author":"ML Reeves","year":"1987","unstructured":"Reeves ML, Leigh PK, England PJ (1987) The identification of a new cyclic nucleotide phosphodiesterase in human and guinea-pig cardiac ventricle. Biochem J 241:535\u2013541","journal-title":"Biochem J"},{"key":"1_CR157_1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/sj.bjp.0704457","volume":"135","author":"A Robichaud","year":"2002","unstructured":"Robichaud A, Savoie C, Stamatiou LN, Jolicoeur P, Rasori R, Chan CC (2002) Assessing the potential of PDE4 inhibitors in rats. Br J Pharmacol 135:113\u2013118","journal-title":"Br J Pharmacol"},{"key":"1_CR158_1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0006-291X(89)92173-6","volume":"163","author":"SA Robicsek","year":"1989","unstructured":"Robicsek SA, Krzanovski JJ, Szentivani A, Polson JB (1989) High pressure liquid chromatography of cyclic ncleotide phosphodiesterase from purified human T-lymphocytes. Biochem Biophys Res Comm 163:554\u2013560","journal-title":"Biochem Biophys Res Comm"},{"key":"1_CR159_1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0006-2952(91)90047-9","volume":"42","author":"SA Robicsek","year":"1991","unstructured":"Robicsek SA, Blanchard DK, Djeu JY, Krzanowski JJ, Szentivani A, Polson JB (1991) Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem Pharmacol 42:869\u2013877","journal-title":"Biochem Pharmacol"},{"key":"1_CR160_1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000090555","volume":"21","author":"B Rosengarten","year":"2005","unstructured":"Rosengarten B, Schermuly RT, Voswinkel R, Kohstall MG, Olschewski H, Weissmann N, Seeger W, Kaps M, Grimminger F, Ghofrani HA (2006) Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension. Cerebrovasc Dis 21:194\u2013200","journal-title":"Cerebrovasc Dis"},{"key":"1_CR161_1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0007-0971(83)90009-8","volume":"77","author":"MR Rudd","year":"1983","unstructured":"Rudd MR, Gellert AR, Studdy PR, Geddes DM (1983) Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M&B 22, 948). Br J Dis Chest 77:78\u201386","journal-title":"Br J Dis Chest"},{"key":"1_CR162_1","first-page":"903","volume":"13","author":"LL Russo","year":"1987","unstructured":"Russo LL, Lebel LA, Koe RB (1987) Effects of selected phosphodiesterase (PDE) inhibitors on calcium-independent PDE activity and rolipram binding sites of cerebral cortex. Soc Neurosci Abstr 13:903","journal-title":"Soc Neurosci Abstr"},{"key":"1_CR163_1","volume-title":"Asthma. Its pathology and treatment","author":"HH Salter","year":"1860","unstructured":"Salter HH (1860) Asthma. Its pathology and treatment. Churchill, London"},{"key":"1_CR164_1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.bjp.0707428","volume":"152","author":"MJ Sanz","year":"2007","unstructured":"Sanz MJ, Cortijo J, Taha MA, Cerd\u00e1-Nicol\u00e1s M, Schatton E, Burgbacher B, Klar J, Tenor H, Schudt C, Issekutz AC, Hatzelmann A, Morcillo EJ (2007) Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability. Br J Pharmacol 152:481\u2013492","journal-title":"Br J Pharmacol"},{"key":"1_CR165_1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(93)90403-5","volume":"230","author":"FU Schade","year":"1993","unstructured":"Schade FU, Schudt C (1993) The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages. Eur J Pharmacol 230:9\u201314","journal-title":"Eur J Pharmacol"},{"key":"1_CR166_1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1164\/ajrccm.160.5.9901102","volume":"160","author":"RT Schermuly","year":"1999","unstructured":"Schermuly RT, Ghofrani HA, Enke B, Weissmann N, Grimminger F, Seeger W, Schudt C, Wallmarath D (1999) Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension. Am J Respir Crit Care Med 160:1500\u20131506","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR167_1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02245738","volume":"102","author":"R Schmiechen","year":"1990","unstructured":"Schmiechen R, Schneider HH, Wachtel H (1990) Close correlation between behavioural response and binding in vivo for inhibitors of rolipram-sensitive phosphodiesterase. Psychopharmacology 102:17\u201320","journal-title":"Psychopharmacology"},{"key":"1_CR168_1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0014-2999(86)90210-4","volume":"127","author":"HH Schneider","year":"1986","unstructured":"Schneider HH, Schmiechen R, Brezinski M, Seidler J (1986) Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur J Pharmacol 127:105\u2013115","journal-title":"Eur J Pharmacol"},{"key":"1_CR221_1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02000605","volume":"22","author":"Wv Schroeder","year":"1887","unstructured":"Schroeder Wv (1887) Ueber die Wirkung des Coffeins als Diuretikum. Arch Exp Path Pharmacol 22:39\u201361","journal-title":"Arch Exp Path Pharmacol"},{"key":"1_CR169_1","first-page":"379","volume":"34","author":"C Schudt","year":"1991","unstructured":"Schudt C, Winder S, Eltze M, Kilian U, Beume R (1991a) Zardaverine: a cyclic AMP specific PDE III\/IV inhibitor. Agents Actions (Suppl) 34:379\u2013402","journal-title":"Agents Actions (Suppl)"},{"key":"1_CR170_1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/BF00174752","volume":"344","author":"C Schudt","year":"1991","unstructured":"Schudt C, Winder S, Forderkunz S, Hatzelmann A, Ullrich V (1991b) Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 344:682\u2013690","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1_CR171_1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0006-2952(91)90694-Z","volume":"42","author":"C Schudt","year":"1991","unstructured":"Schudt C, Winder S, Mueller B, Ukena D (1991c) Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol 42:153\u2013161","journal-title":"Biochem Pharmacol"},{"key":"1_CR172_1","first-page":"A183","volume":"147","author":"C Schudt","year":"1993","unstructured":"Schudt C, Tenor H, Wendel A, Eltze M, Magnussen H, Rabe KF (1993) Influence of the PDEIII\/IV inhibitor B9004-070 on contraction and PDE activities in airway and vascular smooth muscle. Am Rev Respir Dis 147:A183","journal-title":"Am Rev Respir Dis"},{"key":"1_CR173_1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0192-0561(93)90052-Z","volume":"15","author":"J Semmler","year":"1993","unstructured":"Semmler J, Wachtel H, Endres S (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-\u03b1 production by human mononuclear cells. Int J Immunopharmac 15:409\u2013413","journal-title":"Int J Immunopharmac"},{"key":"1_CR174_1","doi-asserted-by":"publisher","first-page":"20575","DOI":"10.1074\/jbc.273.32.20575","volume":"273","author":"J Seybold","year":"1998","unstructured":"Seybold J, Newton R, Wright L, Finney PA, Suttorp N, Barnes PJ, Adcock IM, Giembycz MA (1998) Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. J Biol Chem 273:20575\u201320588","journal-title":"J Biol Chem"},{"issue":"6","key":"1_CR175_1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1165\/rcmb.2009-0297OC","volume":"43","author":"SM Simet","year":"2009","unstructured":"Simet SM, Sisson JH, Pavlik JA, Devasure JM, Boyer C, Liu X, Kawasaki S, Sharp JG, Rennard SI, Wyatt TA (2009) Long-term cigarette smoke exposure in a mouse model of ciliated epithelial cell function. Am J Respir Cell Mol Biol 43(6):635\u2013640","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1_CR176_1","volume-title":"Phosphodiesterase inhibitors","author":"JE Souness","year":"1996","unstructured":"Souness JE (1996) Characterization of different states of PDE4 by rolipram and RP 73401. In: Schudt C, Dent G, Rabe KF (eds) Phosphodiesterase inhibitors. Academic, London"},{"key":"1_CR177_1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","volume":"118","author":"JE Souness","year":"1996","unstructured":"Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman N, Karlsson J-A (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF generation from human monocytes by interacting with a \u201clow affinity\u201d phosphodiesterase 4 conformer. Br J Pharmacol 118:649\u2013658","journal-title":"Br J Pharmacol"},{"key":"1_CR178_1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/sj.bjp.0701200","volume":"121","author":"JE Souness","year":"1997","unstructured":"Souness JE, Houghton C, Sardar N, Withnall MT (1997) Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin-2 release from murine splenocytes by interacting with a \u201clow-affinity\u201d phosphodiesterase 4 conformer. Br J Pharmacol 121:743\u2013750","journal-title":"Br J Pharmacol"},{"key":"1_CR179_1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/1523-1747.ep12531617","volume":"73","author":"MA Stawiski","year":"1979","unstructured":"Stawiski MA, Rusin LJ, Burns TL, Weinstein GD, Voorhees JJ (1979) Ro 20-1724: an agent that significantly improves psoriatric lesions in double-blind clinical trials. J Invest dermatol 73:261\u2013263","journal-title":"J Invest dermatol"},{"key":"1_CR182_1","doi-asserted-by":"crossref","first-page":"L165","DOI":"10.1152\/ajplung.2001.280.1.L165","volume":"280","author":"K Takeyama","year":"2001","unstructured":"Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, Protin U, Kroschel P, Nadel JA (2001) Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280:L165\u201372","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1_CR183_1","volume-title":"Phosphodiesterase inhibitors","author":"H Tenor","year":"1996","unstructured":"Tenor H, Schudt C (1996) Analysis of PDE isoenzyme profiles in cells and tissues by pharmacological methods. In: Schudt C, Dent G, Rabe KF (eds) Phosphodiesterase inhibitors. Academic, London"},{"key":"1_CR184_1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/1523-1747.ep12313330","volume":"105","author":"H Tenor","year":"1995","unstructured":"Tenor H, Hatzelmann A, Wendel A, Schudt C (1995a) Identification of phosphodiesterase IV activity and its cyclic adenosine monophosphate-dependent up-regulation in a human keratinocyte cell line (HACAT). J Invest Dermatol 105:70\u201374","journal-title":"J Invest Dermatol"},{"key":"1_CR185_1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1365-2222.1995.tb01109.x","volume":"25","author":"H Tenor","year":"1995","unstructured":"Tenor H, Staniciu L, Schudt C, Hatzelmann A, Wendel A, Djukanovic R, Church MK, Shute JK (1995b) Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes. Clin Exp Allergy 25:616\u2013624","journal-title":"Clin Exp Allergy"},{"key":"1_CR186_1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2222.1995.tb01110.x","volume":"25","author":"H Tenor","year":"1995","unstructured":"Tenor H, Hatzelmann A, Kupferschmidt R, Staniciu L, Djukanovic R, Schudt C, Wendel A, Church MK, Shute JK (1995c) Cyclic nucleotide phosphodiestererase isoenzyme activities in human alveolar macrophages. Clin Exp Allergy 25:625\u20136333","journal-title":"Clin Exp Allergy"},{"key":"1_CR187_1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1476-5381.1996.tb15598.x","volume":"118","author":"H Tenor","year":"1996","unstructured":"Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK (1996) Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 118:1727\u20131735","journal-title":"Br J Pharmacol"},{"key":"1_CR188_1","first-page":"717s","volume":"26","author":"H Tenor","year":"2005","unstructured":"Tenor H, Burgbacher B, Schudt C, Hatzelmann A (2005) Effects of roflumilast and other PDE4 inhibitors on human CD8+ T-cell functions. Eur Respir J Suppl 26:717s","journal-title":"Eur Respir J Suppl"},{"key":"1_CR189_1","volume-title":"Chronic obstructive pulmonary disease","author":"H Tenor","year":"2007","unstructured":"Tenor H, Bundschuh D, Schudt C, Bredenbr\u00f6ker D, Hatzelmann A (2007) Phosphodiesterase 4 inhibitors in the treatment of COPD. In: Stockley RS, Renard SI, Rabe KF, Celli B (eds) Chronic obstructive pulmonary disease. Blackwell, Oxford"},{"key":"1_CR190_1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/bi00800a014","volume":"10","author":"WJ Thompson","year":"1971","unstructured":"Thompson WJ, Appleman MM (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10:311\u2013316","journal-title":"Biochemistry"},{"key":"1_CR191_1","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1016\/S0021-9258(17)33203-9","volume":"251","author":"WJ Thompson","year":"1976","unstructured":"Thompson WJ, Ross CP, Pledger WJ, Strada SJ, Banner RL, Hersh EM (1976) Cyclic adenosine 3\u2032:5\u2032-monophosphate phosphodiesterase: distinct forms in human lymphocytes and monocytes. J Biol Chem 251:4922\u20134929","journal-title":"J Biol Chem"},{"key":"1_CR192_1","first-page":"69","volume":"10","author":"WJ Thompson","year":"1979","unstructured":"Thompson WJ, Terasaki WL, Epstein PM, Strada SJ (1979) Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv Cyclic Nucl Res 10:69\u201392","journal-title":"Adv Cyclic Nucl Res"},{"key":"1_CR193_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1164\/ajrccm.149.2.8306036","volume":"149","author":"JR Thorne","year":"1994","unstructured":"Thorne JR, Broadley KJ (1994) Adenosine-induced bronchoconstriction in conscious hyperresponsive and sensitized guinea-pigs. Am J Respir Crit Care Med 149:392\u2013399","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR194_1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1164\/ajrccm.152.5.7582302","volume":"152","author":"KJ Thusu","year":"1995","unstructured":"Thusu KJ, Morin FC, Russell JA, Steinhorn RA (1995) The cGMP phosphodiesterase inhibitor zaprinast enhances the efffect of nitric oxide. Am J Respir Crit Care Med 152:1605\u20131610","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR195_1","doi-asserted-by":"publisher","first-page":"L959","DOI":"10.1152\/ajplung.00508.2007","volume":"296","author":"S Togo","year":"2009","unstructured":"Togo S, Liu X, Wang X, Sugiura H, Kamio K, Kawasaki S, Kobayashi T, Ertl RF, Ahn Y, Holz O, Magnussen H, Fredriksson K, Skold CM, Rennard SI (2009) The PDE4 inhibitors roflumilast and rolipran augment PGE2 inhibition of TGF\u00df1 stimulated fibroblasts. Am J Physiol Lung Cell Mol Physiol 296:L959\u2013L969","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1_CR196_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.1993.tb13439.x","volume":"108","author":"A Tomkinson","year":"1993","unstructured":"Tomkinson A, Karlsson J-A, Raeburn D (1993) Comparison of the effects of selective inhibitors of phosphodiesterase type III an IV in airway smooth muscle with differing \u00df-adrenoceptor subtypes. Br J Pharmacol 108:57\u201361","journal-title":"Br J Pharmacol"},{"key":"1_CR197_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0026-895X(25)09968-7","volume":"37","author":"TJ Torphy","year":"1989","unstructured":"Torphy TJ, Cieslinsky LB (1989) Characterization and selective Inhibition of cyclic nucleotide phosphodiesterase isoenzymes in canine tracheal smooth muscle. Mol Pharmacol 37:206\u2013214","journal-title":"Mol Pharmacol"},{"key":"1_CR198_1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/thx.46.7.512","volume":"46","author":"TJ Torphy","year":"1991","unstructured":"Torphy TJ, Undem BJ (1991) Phosphodiesterase inhibitors: new opportunities for treatment of asthma. Thorax 46:512\u2013523","journal-title":"Thorax"},{"key":"1_CR199_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0022-3565(25)22186-3","volume":"246","author":"TJ Torphy","year":"1988","unstructured":"Torphy TJ, Burman M, Huang LB, Tucker SS (1988) Inhibition of the low Km cyclic AMP phosphodiesterase in intact canine trachealis by SKF 94863: mechanical and biochemical responses. J Pharmacol Exp Ther 246:843\u2013850","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR200_1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0022-3565(25)10457-6","volume":"263","author":"TJ Torphy","year":"1992","unstructured":"Torphy TJ, Zhou HL, Cieslinski LB (1992a) Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulatis cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 263:1195\u20131205","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR201_1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0021-9258(18)46016-4","volume":"267","author":"TJ Torphy","year":"1992","unstructured":"Torphy TJ, Stadel JM, Burman M, Cieslinski LB, McLaughlin MM, With JR, Livi GP (1992b) Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. J Biol Chem 267:1796\u20131804","journal-title":"J Biol Chem"},{"key":"1_CR202_1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0022-3565(25)38243-1","volume":"265","author":"TJ Torphy","year":"1993","unstructured":"Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW (1993) Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 265:1213\u20131223","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR203_1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01940739","volume":"69","author":"O Trendelenburg","year":"1912","unstructured":"Trendelenburg O (1912) Physiologische und pharmakologische Untersuchungen an der isolierten Bronchialmuskulatur. Arch Exp Path Pharmacol 69:79\u2013107","journal-title":"Arch Exp Path Pharmacol"},{"key":"1_CR204_1","volume-title":"Chronic obstructive lung disease","author":"RM Tudor","year":"2002","unstructured":"Tudor RM, Voelkel NF (2002) The pathobiology of chronic bronchitis and emphysema. In: Voelkel NF, MacNee W (eds) Chronic obstructive lung disease. BC Decker, London"},{"key":"1_CR205_1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0022-3565(25)38342-4","volume":"266","author":"DC Underwood","year":"1993","unstructured":"Underwood DC, Osborn RR, Novak LB, Matthews JK, Newsholme SJ, Undem BJ, Hand JM, Torphy TJ (1993) Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cAMP-specific phosphodiesterase inhibitor rolipram. J Pharmacol Exp Ther 266:306\u2013313","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR206_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0022-3565(25)22360-6","volume":"270","author":"DC Underwood","year":"1994","unstructured":"Underwood DC, Kotzer CJ, Bochnovicz S, Osborn RR, Luttmann MA, Hay DWP, Torphy TJ (1994) Comparison of Phosphodiesterase III, IV and dual III\/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther 270:250\u2013259","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR207_1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0026-895X(25)08757-7","volume":"47","author":"MW Verghese","year":"1995","unstructured":"Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin C (1995) Regulation of distinct cyclic AMP-specific phosphodiesterase (posphodiesterase type 4) isozymes in human monocytic cells. Mol Pharmacol 47:1164\u20131171","journal-title":"Mol Pharmacol"},{"key":"1_CR208_1","first-page":"9","volume":"15","author":"R Virag","year":"1981","unstructured":"Virag R, Zwang G, Dermange H, Legman M (1981) Vasculogenic impotence: a review of 92 cases in 54 surgical operations. Vasc Sug 15:9\u201317","journal-title":"Vasc Sug"},{"key":"1_CR209_1","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-29837-1","volume-title":"Drug discovery and evaluation","author":"HG Vogel","year":"2002","unstructured":"Vogel HG (2002) Drug discovery and evaluation. Springer, Heidelberg"},{"key":"1_CR210_1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF01243273","volume":"56","author":"H Wachtel","year":"1983","unstructured":"Wachtel H (1983) Species differences in behavioural effects of rolipram and other adenosine cyclic 3, 5-monophosphate phosphodiesterase inhibitors. J Neural Transm 56:139\u2013152","journal-title":"J Neural Transm"},{"key":"1_CR211_1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0028-3908(86)90159-0","volume":"25","author":"H Wachtel","year":"1986","unstructured":"Wachtel H, Schneider HH (1986) Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology 25:1119\u20131126","journal-title":"Neuropharmacology"},{"key":"1_CR213_1","unstructured":"Weidenbach A, Braun C, Schwoebel F, Beume R, Marx D (2008a) Steroid-insensitivity in a short-term model of cigarette smoke-induced pulmonary inflammation in mice. Am J Respir Crit Care Med (Suppl) A651 (abstract)"},{"key":"1_CR214_1","unstructured":"Weidenbach A, Braun C, Schwoebel F, Beume R, Marx D (2008b) Therapeutic effects of various PDE4 inhibitors on cigarette smoke-induced pulmonary neutrophilia in mice. Am J Respir Crit Care Med (Suppl) A651 (abstract)"},{"key":"1_CR215_1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1021\/jm50001a001","volume":"28","author":"RE Weishaar","year":"1985","unstructured":"Weishaar RE, Cain MH, Bristol JA (1985) A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J Med Chem 28:537\u2013545","journal-title":"J Med Chem"},{"key":"1_CR216_1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ddr.430030604","volume":"3","author":"RE Weisshaar","year":"1983","unstructured":"Weisshaar RE, Quade M, Boyd D, Schenden J, Marks S, Kaplan HR (1983) The effect of several \u201cnew and novel\u201d cardiotonic agents on key subcellular processes involved in the regulation of myocardial contractility: implications for mechanism of action. Drug Dev Res 3:517\u2013534","journal-title":"Drug Dev Res"},{"key":"1_CR218_1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0165-6147(88)90031-4","volume":"9","author":"B Wetzel","year":"1988","unstructured":"Wetzel B, Hauel N (1988) New cardiotonic agents \u2013 a promising approach for treatment of heart failure. Trends Pharmacol Res 9:166\u2013170","journal-title":"Trends Pharmacol Res"},{"key":"1_CR219_1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF00542147","volume":"26","author":"JH Wilkens","year":"1984","unstructured":"Wilkens JH, Neuenkirchen H, Sybrecht GW, Oellerich M (1984) Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method. Eur J Clin Pharmacol 26:491\u2013498","journal-title":"Eur J Clin Pharmacol"},{"key":"1_CR220_1","unstructured":"Wohlsen A, Wollin L, Marx D, Beume R (2006). Effect of roflumilast and other cAMP elevating agents on airway beat ciliary frequency in proximal and distal airways in rat precision cut lung slices. Fifth international multidisciplinary Conference on Chronic Obstructive Pulmonary Disease (COPD5), June 28\u201330, Birmingham, UK: Poster P25."}],"container-title":["Handbook of Experimental Pharmacology","Phosphodiesterases as Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-17969-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:38:46Z","timestamp":1741264726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-17969-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642179686","9783642179693"],"references-count":212,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-17969-3_1","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"6 May 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}